In this episode, Michelle introduces the ProtGPS model, emphasizing its transformative potential in medical research. She delves into the University of Washington's Baker Lab's breakthrough in creating AI-generated enzymes, highlighting the implications for biotechnology. The episode also covers Anthropic's latest AI model, focusing on its innovative sliding scale feature that enhances flexibility and adaptability. Michelle concludes with a sign-off, summarizing the key points discussed and their significance in the evolving landscape of artificial intelligence.
(0:00) Introduction and episode date
(0:27) ProtGPS model and its significance in medical research
(2:38) AI-generated enzymes by the University of Washington's Baker Lab
(5:15) Anthropic's new AI model and sliding scale feature
(7:08) Conclusion and sign-off